Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFST.L Regulatory News (FST)

  • There is currently no data for FST

Toumaz Employee Long Term Incentive Plan

28 Jan 2015 08:00

RNS Number : 3074D
Toumaz Limited
28 January 2015
Β 

28 January 2015

Β 

Toumaz Limited

("Toumaz" or the "Company")

Β 

Toumaz Employee Long Term Incentive Plan ("LTIP")

Β 

Toumaz Limited (AIM: TMZ) announces that on 30th January 2015, the Company's Employee Benefit Trust, together with participating employees and directors of the Company, will jointly subscribe for 24,865,103 new ordinary shares of 0.25p each in the capital of the Company ("Ordinary Shares") at a price of 0.25p per Ordinary Share ("JSOP Shares"). The Company also announces that on that same date the Company will grant options over 5,556,495 Ordinary Shares under the Toumaz Limited 2012 Unapproved Share Option Scheme to employees of the Company and Non-Executive Director, Prof Christofer Toumazou.

Β 

The following Directors of the Company have been granted awards under the 2013 Joint Share Option Plan or 2012 Unapproved Share Option Scheme:

Β 

Name and title of Director

Allocation of shares jointly held in the JSOP

Total interest in JSOP Shares following the award

Number of options granted

Β 

Total options granted following the award

Anthony Sethill, Chief Executive Officer

7,200,000

25,000,000

-

-

Jonathan Apps, Chief Financial Officer

6,000,000

15,000,000

-

-

Christofer Toumazou, Non-Executive Director

-

6,000,000

2,000,000

12,305,835

Β 

Application has been made for the 24,865,103 JSOP Shares to be admitted to trading on AIM expected to be effective on 30th January 2015.

Β 

Vesting of the JSOP and unapproved award issued to Directors are subject to the following performance criteria. All of the award will be subject to the share price attaining an average closing mid-market price of 15p for 90 days by 30th January 2020. This vesting will neither be triggered before 30th January 2018 nor after 30th January 2020.

Β 

Total Voting Rights and Share Capital

Β 

Following the admission of the JSOP Shares, Toumaz will have a total issued share capital of 1,702,731,503 Ordinary Shares.

Β 

There are 105,347,854 Ordinary Shares held jointly by the Employee Benefit Trust and participants for the purposes of the Company's joint share ownership plan in relation to which all voting rights have been waived.

Β 

Therefore the total number of 1,597,383,649 Ordinary Shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the Disclosure and Transparency Rules.

Β 

For Further Enquiries:

Β 

Toumaz Limited

+44 (0) 207 391 0620

Anthony Sethill, Chief Executive Officer

Β 

Jonathan Apps, Chief Financial Officer

Β 

Β 

Β 

Peel Hunt LLP (Nominated Adviser and Broker)

+44 (0) 207 418 8900

Richard Kauffer/Daniel Harris

Β 

Β 

Β 

Instinctif Partners

+44 (0) 207 457 2020

Adrian Duffield/Chantal Woolcock

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCBRMRTMBTTBTA
Date   Source Headline
20th Feb 201210:16 amRNSHolding(s) in Company
16th Feb 20127:00 amRNSCompletion of placing
13th Feb 20127:00 amRNSPlacing raises £11.2m
13th Feb 20127:00 amRNSTrading update
3rd Jan 20127:00 amRNSSubsidiary established with Imagination Technologi
24th Oct 20117:00 amRNSTelran distribution clearance
21st Sep 20117:00 amRNSHalf year results
9th Aug 20114:52 pmRNSNotice of Results
29th Jul 20117:00 amRNSHalf year trading update
11th Jul 20117:00 amRNSFDA approval for Sensium
11th Jul 20117:00 amRNSJV established with CCE
5th May 20115:24 pmRNSResult of AGM
29th Mar 20117:00 amRNSFull year results
16th Mar 20113:16 pmRNSNotice of Results
16th Mar 20113:05 pmRNSHolding(s) in Company
3rd Mar 20114:34 pmRNSIssue of Equity
2nd Mar 20118:14 amRNS£1.8m Raised
10th Feb 20117:41 amRNSStrategic Investment
1st Feb 20117:00 amRNSTELRAN Launch
1st Feb 20117:00 amRNSYear End Trading Update
30th Nov 20107:00 amRNSXENIF processor in production
15th Sep 20107:00 amRNSInterim Results
24th Aug 20109:33 amRNSIssue of Equity
11th Aug 201011:52 amRNSNotice of Results
27th Jul 20107:00 amRNSLicense agreement
15th Jul 201010:19 amRNSIssue of Equity and Exercise of Options
30th Jun 20107:00 amRNSTrading Update
16th Jun 20108:49 amRNSAnnual Financial Report
26th May 20109:07 amRNSChange of Name
10th May 20102:52 pmRNSResult of AGM
30th Mar 20107:00 amRNSFinal Results
12th Mar 20109:00 amRNSQuanta takes strategic stake
11th Mar 20104:27 pmRNSDirector dealings
10th Mar 201011:26 amRNSNotice of Results
23rd Feb 20107:00 amRNSClinical Trial Update
1st Feb 20102:02 pmRNSExercise of Options - replacement
29th Jan 201012:33 pmRNSExercise of Options
22nd Dec 200911:19 amRNSHolding(s) in Company
21st Dec 20097:00 amRNSHolding(s) in Company
17th Dec 20093:10 pmPRNResult of EGM
14th Dec 20093:34 pmPRNDirector/PDMR Shareholding
1st Dec 20097:00 amPRNProposed Placing and Update
9th Nov 20091:20 pmRNSNational Microelectronics Institute Award
2nd Nov 20097:00 amPRNSensium Digital Plaster European Trial
28th Sep 20097:00 amPRNHalf-yearly Report
22nd Sep 200912:16 pmRNSHolding(s) in Company
11th Sep 20097:00 amRNSCorrection re holding in company
10th Sep 20097:00 amRNSHolding(s) in Company
7th Aug 200912:01 pmRNSHolding(s) in Company
22nd Jul 200911:21 amPRNResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.